Editorial on the Research Topic Biomaterial advances in intervertebral disc degenerationNeck and back pain are ubiquitous in modern society, leading to serious lifelong disability and placing an enormous socioeconomic burden on the global healthcare system. Although the etiology of neck and back pain is multifaceted and still incompletely understood, intervertebral disc degeneration (IDD) is considered to be the most significant contributor. The current treatments for IDD, including medication, surgery, and others, are limited to symptomatic relief but fail to restore the structure and homeostasis of the intervertebral disc. The failure leads to the steady deterioration of compromised discs and undesirable consequences, such as recrudescence or adjacent vertebral disease. Tissueengineered approaches hold great promise for the treatment of IDD. Gullbrand et al. designed and manufactured a disc-like angle ply structure (DAPS), which has distinct components that mimic the structure of the native disc. The long-term integration and mechanical function of engineered DAPS in vivo, even in large animal models have been successfully tested (Gullbrand et al., 2018). After that, Sloan et al. demonstrated that combined nucleus pulposus augmentation using hyaluronic acid injection and annulus fibrosus repair using photo cross-linked collagen patch restore nucleus pulposus hydration, heal annulus fibrosus defects and maintain native torsional and compressive stiffness up to 6 weeks after discectomy injury in a large animal model. These studies move this approach a step towards translational feasibility (Sloan et al., 2020).Given the indispensable role of biomaterials in tissue engineering for IDD, we prepared this Research Topic to summarize the progress in this field. The harsh microenvironment of IDD is not suitable for disc regeneration. Therefore, various therapeutic agents, including small molecular, growth factor, exosome, and nucleic acids-based drugs are employed to reduce the inflammatory response, promote extracellular matrix synthesis, and direct cell differentiation to create a good regenerative microenvironment. Traditional drug delivery such as systemic administration or via in situ injection has low drug availability and high offtarget toxicity. Liu et al. have systematically demonstrated that biomaterials-based nanodrug delivery systems have improved treatment results of therapeutic agents for IDD because of their good biodegradability, biocompatibility, precise targeted specific drug delivery, prolonged drug release time, and enhanced drug efficacy (Liu et al., 2023). Except for drug delivery, a good cell carrier is critical for tissue regeneration. The microsphere is a class of three-dimensional spherical structures with an average particle size of 1-1000 μm that could be used in cell carrying and biomedical substance delivery. Guo et al. recently reviewed the use of various microspheres for disc regeneration and clearly demonstrated that the high